- Home
- MYGN vs OSW Comparison
MYGN vs OSW Comparison
Compare MYGN & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- OSW
- Stock Information
- Founded
- MYGN 1991
- OSW 2017
- Country
- MYGN United States
- OSW Bahamas
- Employees
- MYGN N/A
- OSW N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- OSW Hotels/Resorts
- Sector
- MYGN Health Care
- OSW Consumer Discretionary
- Exchange
- MYGN Nasdaq
- OSW Nasdaq
- Market Cap
- MYGN 744.7M
- OSW 2.1B
- IPO Year
- MYGN 1995
- OSW N/A
- Fundamental
- Price
- MYGN $4.51
- OSW $21.57
- Analyst Decision
- MYGN Hold
- OSW Strong Buy
- Analyst Count
- MYGN 15
- OSW 4
- Target Price
- MYGN $15.14
- OSW $21.25
- AVG Volume (30 Days)
- MYGN 1.3M
- OSW 512.3K
- Earning Date
- MYGN 08-05-2025
- OSW 07-30-2025
- Dividend Yield
- MYGN N/A
- OSW 0.75%
- EPS Growth
- MYGN N/A
- OSW 84.76
- EPS
- MYGN N/A
- OSW 0.63
- Revenue
- MYGN $831,300,000.00
- OSW $903,423,000.00
- Revenue This Year
- MYGN N/A
- OSW $7.54
- Revenue Next Year
- MYGN $6.68
- OSW $8.16
- P/E Ratio
- MYGN N/A
- OSW $33.96
- Revenue Growth
- MYGN 7.38
- OSW 9.80
- 52 Week Low
- MYGN $3.81
- OSW $14.21
- 52 Week High
- MYGN $29.30
- OSW $23.01
- Technical
- Relative Strength Index (RSI)
- MYGN 40.01
- OSW 65.23
- Support Level
- MYGN $4.97
- OSW $21.14
- Resistance Level
- MYGN $5.37
- OSW $21.72
- Average True Range (ATR)
- MYGN 0.28
- OSW 0.44
- MACD
- MYGN -0.07
- OSW -0.02
- Stochastic Oscillator
- MYGN 2.34
- OSW 82.61
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.